Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics
Gene replacement therapy with oncosuppressor microRNAs (miRNAs) is a promising alternative to interfere with cancer progression. However, miRNAs are highly inefficient in a biological environment, hampering a successful translation to clinics. Nanotechnology can tackle this drawback by providing del...
Saved in:
Main Authors: | Surasa Nagachinta (Author), Belen Lopez Bouzo (Author), Abi Judit Vazquez-Rios (Author), Rafael Lopez (Author), Maria de la Fuente (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miRNA Delivery by Nanosystems: State of the Art and Perspectives
by: Fernanda C. Moraes, et al.
Published: (2021) -
Modulation of Colorectal Tumor Behavior via lncRNA TP53TG1-Lipidic Nanosystem
by: Farimah Masoumi, et al.
Published: (2021) -
Regulation of miRNA content. Part 1. Editing miRNA. Тailing miRNA
by: A.E. Abaturov, et al.
Published: (2021) -
MiRNA biogenesis. Part 1. Maturation of pre-miRNA. Maturation of canonical miRNAs
by: A.E. Abaturov, et al.
Published: (2021) -
AGO-accessible anticancer siRNAs designed with synergistic miRNA-like activity
by: Dowoon Gu, et al.
Published: (2021)